isatin has been researched along with pyrimidinones in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bal, TR; Sriram, D; Yogeeswari, P | 1 |
Jayarambabu, N; Maddela, S; Makula, A | 1 |
Devale, TL; Miniyar, P; Murumkar, P; Parikh, J; Sharma, P; Shrivastava, B | 1 |
3 other study(ies) available for isatin and pyrimidinones
Article | Year |
---|---|
Newer aminopyrimidinimino isatin analogues as non-nucleoside HIV-1 reverse transcriptase inhibitors for HIV and other opportunistic infections of AIDS: design, synthesis and biological evaluation.
Topics: AIDS-Related Opportunistic Infections; Drug Design; HIV Reverse Transcriptase; Humans; Isatin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrimidinones; Virus Replication | 2005 |
Fe3O4 Nanoparticles Mediated Synthesis of Novel Isatin-dihydropyrimidinone Hybrid Molecules as Antioxidant and Cytotoxic Agents.
Topics: Antineoplastic Agents; Antioxidants; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Ferrosoferric Oxide; Humans; Isatin; Molecular Structure; Nanoparticles; Particle Size; Pyrimidinones; Structure-Activity Relationship | 2017 |
Dihydropyrimidinone-isatin hybrids as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
Topics: Anti-HIV Agents; Drug Design; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Isatin; Molecular Docking Simulation; Pyrimidinones; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2017 |